Search results
Results From The WOW.Com Content Network
Guideline Population Goal blood pressure (mmHg) Initial treatment options ESC 2024 [2] General 120–129/70–79 BP >140/90: Two from different classes: preferably RAS-inhibitor (ACEI or ARB) with either thiazide diuretic/thiazide-like diuretic or dihydropyridine CCB. ESH 2023 [3] General age <65 General age 65–79 General age ≥80 <130/80 ...
In addition, the journal features reviews, clinical perspectives, podcasts, and editorial articles about recent developments in cardiology, and encourages correspondence from its readers. Another important aspect of the journal are the ESC Clinical Practice Guidelines, which cover all areas of cardiology.
The European Society of Cardiology (ESC) is an independent non-profit, non-governmental professional association that works to advance the prevention, diagnosis and management of diseases of the heart and blood vessels, and improve scientific understanding of the heart and vascular system. [2]
The European Society of Cardiology (ESC), [21] and National Institute for Health and Care Excellence (NICE) [23] guidelines recommend that if the patient has a CHA 2 DS 2-VASc score of 2 and above, oral anticoagulation therapy (OAC) with a vitamin K antagonist (VKA, e.g. warfarin with target INR of 2-3) or one of the direct oral anticoagulant ...
Commonly prescribed drugs are prescribed according to guidelines around the world. For instance, for ischemic heart disease, the American College of Cardiology/American Heart Association (ACC/AHA) guideline is used in the United States and the European Society of Cardiology (ESC) guideline is used in Europe.
After the 2017 ESC Congress, Barcelona became the city with most congresses since 1988(6), followed by Stockholm (5) and then by Amsterdam and Vienna and Munich (4 times each as of 2018). Some congresses (1994 and 2006) were organised jointly with the World Heart Federation [ 2 ] under the name of "World Congress of Cardiology".
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
Rhian Merry Touyz Koppel (born September 14, 1959) is a Canadian medical researcher.She is currently serving as the Executive Director and Chief Scientific Officer [1] of the Research Institute of the McGill University Health Centre in Montreal, Canada, since 2021.